Subscribe Now

* You will receive the latest news and updates on your favorite celebrities!

Trending News

Adults & T1D

T1D Exchange Announces Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes 

T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.

T1D Exchange Coordinates With Local Authorities to Provide Hand Sanitizer and Medical Supplies 

With the COVID-19 coronavirus continuing to spread and disrupt daily life, supply chains and medical operations, there is an increasing need for access to vital basics such as hand sanitizer. Through an ongoing partnership with MassBio, we were able to answer the call – along with numerous other organizations – as to how we can …

Get Involved

Real World Evidence: What It Means and Why it Matters for Type 1 Diabetes 

People living with type 1 diabetes learn, in many ways, to be research scientists and investigators of their own lives. We learn how slices of pizza or a plate of spaghetti affects our blood sugar, and how to mediate those effects with multiple boluses of insulin or a long-lasting dose. We discover precisely how much sugar we need to stay steady during an intense workout session.

In doing so, we begin to learn about the meaning and applications of real-world data and evidence. Modern medical and scientific research takes several different approaches to investigation, from randomized, controlled clinical trials to longitudinal, observational studies that examine how people live with various conditions and therapies in the real world.

Blood sugar management

Diasome Announces Positive Results for HDV Insulin Additive to Manage Blood Sugar 

Diasome Pharmaceuticals announced positive results this week from a Phase 2 study of its injectable hepatocyte directed vesicle (HDV) additive for insulin in patients with type 1 diabetes. The news could prove a major step forward for therapies that aim to improve and optimize the way insulin is used and metabolized by the body. In …

WordPress Theme built by Shufflehound. © 2020 T1D Exchange. All Rights Reserved.